Full Text View
Tabular View
No Study Results Posted
Related Studies
Clonidine Versus Midazolam for Premedication
This study has been completed.
First Received: March 12, 2008   Last Updated: March 18, 2008   History of Changes
Sponsored by: University of Schleswig-Holstein
Information provided by: University of Schleswig-Holstein
ClinicalTrials.gov Identifier: NCT00638729
  Purpose

alpha2-agonists like clonidine offer several useful effects that make these drugs an interesting alternative to benzodiazepines for pharmacological premedication. We therefore sought to determine the effect of pre-anesthetic medication with clonidine vs. midazolam in a randomized, double-blind, placebo controlled study. Effects of pre-anesthetic medication were assessed on (1) bispectral index (BIS),(2) sedation score and visual analog scales for anxiety and pain, (3) neuropsychologic tests to assess cognitive function and (4) circulating stress hormones.


Condition Intervention
Anxiety
Pain
Drug: midazolam
Drug: clonidine
Drug: placebo

Study Type: Interventional
Study Design: Supportive Care, Randomized, Double Blind (Subject, Caregiver, Outcomes Assessor), Placebo Control, Parallel Assignment
Official Title: Effects of Clonidine and Midazolam Premedication on Bispectral Index and Recovery After Elective Surgery

Resource links provided by NLM:


Further study details as provided by University of Schleswig-Holstein:

Primary Outcome Measures:
  • Effect of premedication on bispectral index [ Time Frame: prior study medication until 2 h postoperatively ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Effect of premedication on postoperative recovery [ Time Frame: prior to study medication until 2 h postoperatively ] [ Designated as safety issue: No ]

Enrollment: 60
Study Start Date: August 2005
Study Completion Date: March 2007
Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Midazolam: Active Comparator
Pre-anesthetic medication with midazolam, 7.5 mg p.o., 60-90 min prior to estimated induction time
Drug: midazolam
midazolam, 7.5 mg p.o., 60-90 min prior to estimated induction time
Clonidine: Active Comparator
pre-anesthetic medication with clonidine, 150 µg p.o., 60-90 min prior to estimated induction time
Drug: clonidine
pre-anesthetic medication with clonidine, 150 µg p.o., 60-90 min prior to estimated induction time
Placebo: Placebo Comparator
Pre-anesthetic medication with an inert tablet, p.o., 60-90 min prior to estimated induction time
Drug: placebo
inert tablet p.o., 60-90 min prior to estimated induction time

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • elective surgery
  • ASA physical status I and II
  • informed consent
  • weight 50 - 100 kg

Exclusion Criteria:

  • cardiovascular disease
  • pregnancy
  • problems of consent due to mentally handicap or language.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00638729

Locations
Germany
Department of Anaesthesiology and Intensive Care Medicine, University of Schleswig-Holstein Campus Kiel
Kiel, Germany, 24105
Sponsors and Collaborators
University of Schleswig-Holstein
Investigators
Study Chair: Jens Scholz, M.D. Chair of the Dept. of Anaesthesiology and Intensive Care Medicine, University of Schleswig-Holstein Campus Kiel
  More Information

Publications:
Responsible Party: Chair of the Department of Anaesthesiology and Intensive Care Medicine, University Schleswig-Holstein Campus Kiel ( Prof. Dr. J. Scholz )
Study ID Numbers: A 157/01, A 157/01
Study First Received: March 12, 2008
Last Updated: March 18, 2008
ClinicalTrials.gov Identifier: NCT00638729     History of Changes
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by University of Schleswig-Holstein:
bispectral index
sedation
stress hormones
cognitive function

Study placed in the following topic categories:
Anesthetics, Intravenous
Neurotransmitter Agents
Tranquilizing Agents
Adrenergic alpha-Agonists
Adrenergic Agents
Clonidine
Psychotropic Drugs
Adjuvants, Immunologic
Central Nervous System Depressants
Stress
Anesthetics
Pain
Cardiovascular Agents
Midazolam
Antihypertensive Agents
Hormones
Adrenergic Agonists
Anesthetics, General
Hypnotics and Sedatives
Anti-Anxiety Agents
Analgesics
Peripheral Nervous System Agents

Additional relevant MeSH terms:
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
GABA Modulators
Physiological Effects of Drugs
Psychotropic Drugs
Anesthetics
Adrenergic Agonists
Sensory System Agents
Therapeutic Uses
Hypnotics and Sedatives
Analgesics
Anesthetics, Intravenous
Sympatholytics
Adrenergic alpha-Agonists
Tranquilizing Agents
Clonidine
Central Nervous System Depressants
Cardiovascular Agents
Midazolam
Antihypertensive Agents
Pharmacologic Actions
Adjuvants, Anesthesia
Anesthetics, General
Autonomic Agents
GABA Agents
Anti-Anxiety Agents
Peripheral Nervous System Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on September 10, 2009